Durable remission achieved in pediatric patients with -positive relapsed/refractory B-cell acute lymphoblastic leukemia by dual CD19- and CD22-targeted chimeric antigen receptor T-cell therapy.
APA
Wan X, Wang T, et al. (2026). Durable remission achieved in pediatric patients with -positive relapsed/refractory B-cell acute lymphoblastic leukemia by dual CD19- and CD22-targeted chimeric antigen receptor T-cell therapy.. Haematologica, 111(1), 340-344. https://doi.org/10.3324/haematol.2024.287023
MLA
Wan X, et al.. "Durable remission achieved in pediatric patients with -positive relapsed/refractory B-cell acute lymphoblastic leukemia by dual CD19- and CD22-targeted chimeric antigen receptor T-cell therapy.." Haematologica, vol. 111, no. 1, 2026, pp. 340-344.
PMID
40400462
같은 제1저자의 인용 많은 논문 (5)
- Cathepsin B mediates HDAC inhibitor-induced epithelial-mesenchymal transition in lung cancer cells.
- Dual-Cascade Activated DNAzyme Nanoreactor within a Zn-Based MOF for Mitochondrial Gene Regulation.
- A nitroreductase-triggered NIR fluorescent probe for selective visualization in orthotopic breast cancer.
- In vitro study on the synergistic effect of curcumin and PD98059 on anti-hepatocarcinoma and antitumor immune escape.
- Comparison of Efficacy on First-Line Helicobacter Pylori Eradication Between Potassium-Competitive Acid Blocker (P-CAB)-Based Therapies Versus Proton-Pump Inhibitor (PPI)-Based Therapies: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.